Clinical Trials | News | Uncategorised SCS response to European Medicines Agency (EMA) and Novartis updates on Crizlanlizumab 31 Jan 2023 As many of you will know Crizanlizumab (Adakveo) was recommended as a new disease modifying... Read More
